| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.vivanzabiosciences.com | |
| Market Cap | 62.00 Cr. | |
| Enterprise Value(EV) | 67.45 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.21 | Trailing Twelve Months Ending 2022-06 |
| Price-Earning Ratio (PE) | 729.41 | Trailing Twelve Months Ending 2022-06 |
| Industry PE | 130.74 | Trailing Twelve Months Ending 2022-06 |
| Book Value / Share | 8.92 | Trailing Twelve Months Ending 2022-06 |
| Price to Book Value | 17.38 | Calculated using Price: 155.00 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.40 Cr. | 4,000,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company is engaged in the business of business of Pharmaceutical Products. | ||
| 1 Day |
|
|
| 1 Week |
|
|
| 1 Month |
|
-20.51% |
| 3 Month |
|
-20.51% |
| 6 Month |
|
-17.84% |
| 1 Year |
|
+15.67% |
| 2 Year |
|
+745.61% |
| 5 Year |
|
-6.06% |
| 10 Year |
|
| 7 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | -242.60 | -17.54 | 5.66 | -12.56 | -6.46 | 2.41 | 10.01 | |
| Return on Capital Employed (%) | -11.38 | -10.82 | 12.73 | -0.40 | 5.74 | 17.11 | 15.64 | |
| Return on Assets (%) | -9.49 | -7.99 | 2.37 | -4.15 | -1.75 | 0.72 | 3.13 |
| Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Shh. Funds | 0 | 4 | 4 | 3 | 3 | 3 | 3 | |
| Non Curr. Liab. | 0 | 1 | 1 | 0 | 3 | |||
| Curr. Liab. | 1 | 3 | 6 | 7 | 9 | 5 | 7 | |
| Minority Int. | ||||||||
| Equity & Liab. | 1 | 7 | 10 | 11 | 12 | 8 | 13 | |
| Non Curr. Assets | 1 | 3 | 3 | 3 | 3 | 3 | 3 | |
| Curr. Assets | 0 | 4 | 7 | 8 | 9 | 5 | 10 | |
| Misc. Exp. not W/O | ||||||||
| Total Assets | 1 | 7 | 10 | 11 | 12 | 8 | 13 |
| Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-06 Rs. Cr. TTM |
| Net Sales | 3 | 6 | 3 | 10 | 10 | 10 | 13 | ||
| Other Income | 0 | 1 | 1 | 1 | 1 | ||||
| Total Income | 4 | 6 | 3 | 10 | 10 | 11 | 13 | ||
| Total Expenditure | 0 | -4 | -6 | -3 | -10 | -10 | -10 | -12 | |
| PBIDT | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Depreciation | 0 | 0 | 0 | ||||||
| Taxation | 0 | 0 | |||||||
| Exceptional Items | 0 | ||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Minority Interest | |||||||||
| Share Associate | |||||||||
| Other Related Items | |||||||||
| Consolidated Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Adjusted EPS | -3 | -1 | 1 | -1 | -1 | 0 | 1 | 0 |
| Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | 0 | 1 | 3 | -3 | |||
| Cash Fr. Inv. | 2 | 0 | ||||||
| Cash Fr. Finan. | 0 | -1 | -1 | -3 | 2 | |||
| Net Change | 0 | -1 | 0 | 0 | 0 | |||
| Cash & Cash Eqvt | -2 | -3 | -3 | -3 | -3 |
|
Tue, 30 Aug 2022
Non-Applicability Of Disclosure Of Related Party Transaction On Consolidated Basis. It is informed that pursuant to regulation 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the provisions of Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended is not applicable to the Company as the Paid Up Share Capital is less than Rs. 10 Crores and Net Worth of the Company is less than Rs. 25 Crores as on 31/03/2022. |
|
Sat, 23 Jul 2022
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015) Vivanza Biosciences Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here |
|
Fri, 22 Jul 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication In terms of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copy of newspaper advertisement published in English daily newspaper (Sunvilla Samachar) and one daily newspaper (Sunvilla Samachar) in Gujarati language of the region where the registered office of the company is situated for extract of Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30 2022. |
| Fri, 16 Sep 2022 |
Opening at High
|
High Decrease 1 Month
|
High Decrease 3 Months
|
High Increase 2 Years
|
CCI Bullish
|
Equities
M.F.
Sectors